Clinuvel says U.S. pricing of rare disorder drug will not top European levels

Australian drugmaker Clinuvel Pharmaceuticals Ltd said on Wednesday the pricing of its recently approved treatment for a rare genetic disorder in the United States will not top its price in Europe.

from Reuters: Company News https://ift.tt/2M04YvO